The project, ‘KIX, novel and innovative drug for treatment of degenerative bone-disorder’, was selected amongst many entries as best business plan for its excellent market understanding.
The award is open to students taking the MSc in Bioentrepreneurship – part of the BioBusiness and Innovation Program, co-founded and co-sponsored by LEO Pharma and other life-science companies.
“LEO Pharma is proud to present this award to students on the BioBusiness and Innovation Program,” says Kim Kjoeller, Senior Vice President, Global Development.
“The life-science industry needs people who not only understand the science behind new developments, but also the complex commercial processes. The award winners demonstrated this knowledge mix, which is essential for future life-science pioneers.”